Znn3bq.jpeg
²é¿´: 631  |  »Ø¸´: 4

rrccwoyun

Òø³æ (³õÈëÎÄ̳)


[ÇóÖú] ÇóÖú European Journal of Medicinal Chemistry.1992,27,413-418 µÄÎÄÏ×

ÇóÖú European Journal of Medicinal Chemistry.1992,27,413-418  µÄÎÄÏ×
ÓÊÏ䣺rrccwoyun@163.com
Óв鵽µÄ·¢ÕâÀлÁË¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yamisr

½ð³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
karl2100(½ð±Ò+1): лл£¡ 2011-08-19 23:37:25
Short communication
Synthesis and platelet activating factor (PAF) receptor antagonist activity of 2,5-diarylcylopentanol derivatives

This article is not included in your organization's subscription. However, you may be able to access this article under your organization's agreement with Elsevier.


M Prashada, JC Tomescha, JR Wareinga, D Larsena and H de Fexa

aSandoz Research Institute, Sandoz Pharmaceuticals Corporation, 59 Route 10, East Hanover, NJ 07936, USA

Received 5 July 1991;  accepted 26 November 1991.  Available online 6 May 2004.

Abstract
Synthesis and platelet activating factor (PAF) receptor antagonist activity of (1¦Á, 2¦Â, 5¦Â)-2,5-diarylcylopentanol derivatives is described. Compounds 2, 4 and 9 showed significant activity.

Keywords: platelet activating factor; diarylcyclopentanols; PAF antagonists


¹ý¿¯ ϲ»µ½  ·½±ã±ðÈ˸øÄãÕÒµ½
ÖÚÉú¶È¾¡·½Ö¤ÆÐÌá,µØÓüδ¿ÕÊIJ»³É·ð¡­¡­
2Â¥2011-08-19 10:41:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

popcosen

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

µÈһϣ¬ÎÒÕÒÈËÀ´°ïÄã²é°É
3Â¥2011-08-19 10:48:26
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

rrccwoyun

Òø³æ (³õÈëÎÄ̳)


ллÁË¡£È«ÊÀ½ç¾Í²îÕâһƪÎÄÏ×ÁË£¬ÐÁ¿à´óÏÀÃÇÁË¡£
4Â¥2011-08-19 12:44:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

popcosen

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
karl2100(½ð±Ò+1): ¶àлÌṩ£¡ 2011-08-19 23:38:23
rrccwoyun(½ð±Ò+8): Ì«¸ÐлÁË 2011-08-20 23:46:21
Çë²éÊÕ£¡Ð»Ð»£¡
5Â¥2011-08-19 20:00:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ rrccwoyun µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] µçÆø¹¤³Ìר˶320Çóµ÷¼Á +5 СÂé×Ó111 2026-04-10 5/250 2026-04-12 10:47 by zhouyuwinner
[¿¼ÑÐ] 291Çóµ÷¼Á +11 ¹ØÒä±±. 2026-04-09 12/600 2026-04-12 10:32 by ÄæË®³Ë·ç
[¿¼ÑÐ] µ÷¼Á +6 ÇàµÆ²»¸º 2026-04-09 6/300 2026-04-11 20:35 by dongdian1
[¿¼ÑÐ] µ÷¼Á +5 ÎĵÀÐÇ̨ 2026-04-11 5/250 2026-04-11 15:01 by ¿­¿­Òª±ä˧
[¿¼ÑÐ] 296Çóµ÷¼Á +6 Íô£¡£¿£¡ 2026-04-09 6/300 2026-04-11 11:25 by zhq0425
[¿¼ÑÐ] 283Çóµ÷¼Á +22 ÄǸöàà×Ó 2026-04-09 22/1100 2026-04-11 10:41 by ÄæË®³Ë·ç
[¿¼ÑÐ] ũѧ0904 312Çóµ÷¼Á +6 Say Never 2026-04-10 6/300 2026-04-11 10:33 by wwj2530616
[¿¼ÑÐ] ²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á +30 @ASDF1234 2026-04-08 32/1600 2026-04-11 10:30 by Delta2012
[¿¼ÑÐ] 346£¬¹¤¿ÆÇóµ÷¼Á +3 moser233 2026-04-09 3/150 2026-04-11 10:04 by zhq0425
[¿¼ÑÐ] 080500Çóµ÷¼Á +17 »ÆÓ 2026-04-06 17/850 2026-04-11 08:36 by zhq0425
[¿¼ÑÐ] 291 Çóµ÷¼Á +29 »¯¹¤2026½ì±ÏÒµÉ 2026-04-09 29/1450 2026-04-10 22:55 by dick_runner
[¿¼ÑÐ] ±¾¿ÆÎ÷¹¤´ó 324Çóµ÷¼Á +4 wysyjs25 2026-04-10 4/200 2026-04-10 20:00 by À´¿´Á÷ÐÇÓê10
[¿¼ÑÐ] Çóµ÷¼ÁÏ£Íû»¹ÊÇÏ£ÍûÔÚɽºÓËÄÊ¡¸½½ü +3 ¿ìÀÖµÄС°×¸ë 2026-04-05 3/150 2026-04-09 17:36 by wp06
[¿¼ÑÐ] 332£¬085601Çóµ÷¼Á +12 ydfyh 2026-04-09 14/700 2026-04-09 17:28 by wp06
[¿¼ÑÐ] 1U¶Ü¼ÇµÃ¼ÇµÃ¾Í +9 sanjin020722 2026-04-08 10/500 2026-04-09 14:11 by Ê«Óë×ÔÓÉ
[¿¼ÑÐ] һ־Ը³¶«´óѧ071000ÉúÎïѧѧ˶³õÊÔ·ÖÊý276Çóµ÷¼Á +3 Ľ¾øcc 2026-04-09 3/150 2026-04-09 09:57 by liuhuiying09
[¿¼ÑÐ] »úеµ÷¼Á +3 zzzbcb 2026-04-07 3/150 2026-04-07 22:19 by hemengdong
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷µç085401Çóµ÷¼Á +4 sunw1306 2026-04-07 4/200 2026-04-07 16:40 by à£à£à£0119
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +5 ´Þwj 2026-04-05 5/250 2026-04-06 15:40 by lin-da
[¿¼ÑÐ] Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ²ÄÁϹ¤³Ì£¬³õÊÔ344Çóר˶µ÷¼Á +6 15933906766 2026-04-05 6/300 2026-04-06 13:21 by Î޼ʵIJÝÔ­
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û